Prognosis
Brazil’s Vaccination Plan Raises More Questions Than Answers
- Plan cites Pfizer shots ‘in negotiation’; CoronaVac not listed
- Poll shows growing number of people don’t want to get vaccines
Vials of Sinovac Biotech Ltd.'s CoronaVac SARS-CoV-2 vaccine.
Photographer: Nicolas Bock/BloombergThis article is for subscribers only.
Brazil’s coronavirus immunization plan released over the weekend did little to assuage concerns that the government is stumbling in its efforts to inoculate 212 million people, with no timeline and vague supply agreements.
The 93-page document published by the health ministry says Brazil has already secured 300 million doses of Covid-19 vaccines, mostly from AstraZeneca Plc. But approval for the Astra shot globally is pending more trials. Other vaccines will be sourced from the Covax facility, organized by the World Health Organization, and some 70 million doses from Pfizer Inc. are “in negotiation.”